BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35627170)

  • 1. Construction of a ceRNA Network and Comprehensive Analysis of lncRNA in Hepatocellular Carcinoma.
    Wang L; Zhao J; Zhu C; Yang K; Zhu L; Liu Y
    Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.
    Zhang L; Tao H; Li J; Zhang E; Liang H; Zhang B
    Aging (Albany NY); 2021 May; 13(12):15990-16008. PubMed ID: 34049287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
    Yang L; Lu P; Yang X; Li K; Chen X; Qu S
    Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer.
    Wang W; Lou W; Ding B; Yang B; Lu H; Kong Q; Fan W
    Aging (Albany NY); 2019 May; 11(9):2610-2627. PubMed ID: 31061236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of a ceRNA network reveals potential prognostic cytoplasmic lncRNAs involved in HCC progression.
    Bai Y; Long J; Liu Z; Lin J; Huang H; Wang D; Yang X; Miao F; Mao Y; Sang X; Zhao H
    J Cell Physiol; 2019 Aug; 234(10):18837-18848. PubMed ID: 30916406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Analysis of Competing Endogenous RNA Network Focusing on Long Noncoding RNA Involved in Cirrhotic Hepatocellular Carcinoma.
    Zhang Y; Chen D; Yang M; Qian X; Long C; Zheng Z
    Anal Cell Pathol (Amst); 2021; 2021():5510111. PubMed ID: 34258170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a ceRNA network and a genomic-clinicopathologic nomogram to predict survival for HBV-related HCC.
    Huang K; Lu Z; Li L; Peng G; Zhou W; Ye Q
    Hum Cell; 2021 Nov; 34(6):1830-1842. PubMed ID: 34487338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of ceRNA network reveals potential prognostic Hint1-related lncRNAs involved in hepatocellular carcinoma progression.
    Zhang C; Bao T; Ke Y; Liu X; Wang X; Liao W; He Y; Wang L
    World J Surg Oncol; 2022 Mar; 20(1):67. PubMed ID: 35241097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated analysis of RNA-seq in hepatocellular carcinoma reveals competing endogenous RNA network composed of circRNA, lncRNA, and mRNA.
    Zhou F; Kang Q; Ma J; Cai J; Chen Y; Qu K; Li F
    Medicine (Baltimore); 2023 Feb; 102(8):e32915. PubMed ID: 36827016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Hypoxia-Related Prognostic Signature and Competing Endogenous RNA Regulatory Axes in Hepatocellular Carcinoma.
    Tang Y; Zhang H; Chen L; Zhang T; Xu N; Huang Z
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a long non-coding RNA-associated ceRNA network reveals potential prognostic lncRNA biomarkers in hepatocellular carcinoma.
    Yan Y; Yu J; Liu H; Guo S; Zhang Y; Ye Y; Xu L; Ming L
    Pathol Res Pract; 2018 Dec; 214(12):2031-2038. PubMed ID: 30316688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.
    Zhang Q; Sun L; Zhang Q; Zhang W; Tian W; Liu M; Wang Y
    Cancer Med; 2020 Dec; 9(24):9219-9235. PubMed ID: 33232580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Analysis of the Sorafenib-Associated Druggable Targets on Differential Gene Expression and ceRNA Network in Hepatocellular Carcinoma.
    Fu Z; Yang G; Wang T; Gao D; Lin D; Liu X
    J Environ Pathol Toxicol Oncol; 2023; 42(4):47-60. PubMed ID: 37522567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence.
    Yan P; Huang Z; Mou T; Luo Y; Liu Y; Zhou B; Cao Z; Wu Z
    BMC Cancer; 2021 Apr; 21(1):436. PubMed ID: 33879119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidate lncRNA-miRNA-mRNA network in predicting hepatocarcinogenesis with cirrhosis: an integrated bioinformatics analysis.
    Zhang R; Jiang YY; Xiao K; Huang XQ; Wang J; Chen SY
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):87-96. PubMed ID: 31758243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of competing endogenous RNA network identifies a poorly differentiated cancer-specific RNA signature for hepatocellular carcinoma.
    Chen QF; Huang T; Si-Tu QJ; Wu P; Shen L; Li W; Huang Z
    J Cell Biochem; 2020 Mar; 121(3):2303-2317. PubMed ID: 31642123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
    Wang R; Hu X; Liu X; Bai L; Gu J; Li Q
    PLoS One; 2021; 16(4):e0249881. PubMed ID: 33861762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of an immune-related ceRNA network in identifying a novel lncRNA signature as a prognostic biomarker for hepatocellular carcinoma.
    Chen R; Chen Y; Huang W; Zhao Y; Luo W; Lin J; Wang Z; Yang J
    Aging (Albany NY); 2021 Jul; 13(13):17607-17628. PubMed ID: 34237706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mRNA, miRNA and lncRNA networks in hepatocellular carcinoma: An integrative transcriptomic analysis from Gene Expression Omnibus.
    Xu JH; Chang WH; Fu HW; Yuan T; Chen P
    Mol Med Rep; 2018 May; 17(5):6472-6482. PubMed ID: 29512731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.